Search Results - Samuel Aballéa
- Showing 1 - 12 results of 12
-
1
Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al by Mondher Toumi, Samuel Aballea
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Measuring health-related quality of life in young children: how far have we come? by Nicola Germain, Samuel Aballéa, Mondher Toumi
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe by Katarzyna Jabłońska, Samuel Aballéa, Pascal Auquier, Mondher Toumi
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results by Junwen Zhou, Aurélie Millier, Clément François, Samuel Aballéa, Mondher Toumi
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer, Philippe Laramée
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach by Ru Han, Shuyao Liang, Clément François, Samuel Aballea, Emilie Clay, Mondher Toumi
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies by Michal Pochopien, Annette Beiderbeck, Phil McEwan, Richard Zur, Mondher Toumi, Samuel Aballéa
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK by Zalmai Hakimi, Con Kelleher, Samuel Aballéa, Khaled Maman, Jameel Nazir, Colette Mankowski, Isaac Odeyemi
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
9
Analysis of health economics assessment reports for pharmaceuticals in France - understanding the underlying philosophy of CEESP assessment by Mondher Toumi, Anastasiia Motrunich, Aurélie Millier, Cécile Rémuzat, Christos Chouaid, Bruno Falissard, Samuel Aballéa
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
10
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models by Michał Pochopień, Ewelina Paterak, Emilie Clay, Justyna Janik, Samuel Aballea, Małgorzata Biernikiewicz, Mondher Toumi
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
11
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease by Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
12
Health economic evaluation of gene replacement therapies: methodological issues and recommendations by Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Postma, Mondher Toumi
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book